Sareum Holdings Competitors and Similar CompaniesClear all
Sareum Holdings's competitors and similar companies include Kiromic Biopharma, RAPT Therapeutics and Alligator Bioscience.
 Sareum Holdings Sareum Holdings discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. |  Kiromic Biopharma Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. |  RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. | ||
Founding Date | Founding Date 2003 | Founding Date 2012 | Founding Date 2015 | Founding Date 2001 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Pampisford, GB HQ | Locations Houston, US HQ | Locations South San Francisco, US HQ | Locations Lund, SE HQ |
Employees | Employees 5 | Employees 4426% increase | Employees 64 | Employees 1555% decrease |
Valuation ($) | Valuation ($) 38.1 m | Valuation ($) 1.8 m | Valuation ($) 69.8 m | Valuation ($) 59 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr514k (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit kr1.1m (FY, 2025) |
Net income | Net income (£4.4m) (FY, 2025) | Net income ($26.9m) (FY, 2024) | Net income ($129.9m) (FY, 2024) | Net income (kr51.4m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 135k | Total funding raised $ 176m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Kiromic Biopharma
HQ
Houston, US
Employees
44↑ 26% increase
Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors.
View companyRAPT Therapeutics
HQ
South San Francisco, US
Employees
64
RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
View company
Alligator Bioscience
HQ
Lund, SE
Employees
15
Alligator develops antibody-based pharmaceuticals for cancer treatment.
View company